Taiwan News2h
BNP PARIBAS GROUP: Signing of the share purchase agreement for AXA Investment Managers by BNP Paribas Cardif
As previously communicated, the agreed price for the acquisition and the long-term partnership is €5.1 billion, with the closing expected mid-2025 and an anticipated impact on BNP Paribas Group's CET1 ...
Taiwan News19h
Elephant Robotics to Exhibit at CES 2025: Featuring Cutting-Edge Innovative Robotics Solutions and AI Bionic Robots Debut
Alongside personal entertainment and convenience, the broad commercial applications of robotics technology are a significant ...
Taiwan News5h
YolTech Therapeutics Announces Successful Completion of Dose Escalation Phase in Phase I Trial of YOLT-201 for ATTR
YolTech Therapeutics today announced updated data from its ongoing Phase I/IIa clinical trial of YOLT-201, a first-in-class CRISPR/Cas9-based in vivo gene-editing therapy for ATTR amyloidosis. The ...
Taiwan News10h
Giftify, Inc. Announces Registered Direct Offering - CORRECTED
Copies of the prospectus supplement and the accompanying prospectus relating to this offering may be obtained, when available, on the SEC’s website at http://www.sec.gov or by contacting Craft Capital ...
Taiwan News13h
CPIC: Deepening Presence in the Greater Bay Area to Promote its Connectivity and Integration
To implement China's national strategy of regional integrated development, CPIC positioned the Greater Bay Area (GBA) as the "high ground of innovation" in 2021.
Taiwan News13h
Immutable Holdings Announces Voting Results for Its Annual General Meeting of Shareholders
Immutable Holdings Inc. (NEO:HOLD) (“Immutable Holdings” or the “Corporation”), a publicly-traded blockchain holding company, is ...
Taiwan News16h
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
The company is led by a management team experienced in the development and commercialization of rare disease therapeutics. Ultragenyx’s strategy is predicated upon time- and cost-efficient drug ...
Taiwan News15h
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte ...
Taiwan News13h
CPIC Life (HK): Based in Hong Kong and Serving the Greater Bay Area via Upgrades of Products/ Services
Company Limited ("CPIC Life (HK)") received the approval from the Hong Kong Insurance Authority to conduct long-term insurance business in Hong Kong, marking the official launch of the company. On the ...
Taiwan News8h
ARMLOGI HOLDING CORP. CLOSES ON $5 MILLION SECOND TRANCHE OF PRE-PAID ADVANCE UNDER A STANDBY EQUITY PURCHASE AGREEMENT
WALNUT, CA, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Armlogi Holding Corp. (“Armlogi” or the “Company”) (Nasdaq: BTOC), a U.S.-based warehousing and logistics service provider that offers a comprehensive ...
Taiwan News8h
Lexicon Announces Receipt of Complete Response Letter for Zynquista™ (sotagliflozin)
THE WOODLANDS, Texas, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced it has received a complete response letter (CRL) from the U.S. Food and Drug ...
Taiwan News16h
Expion360 Announces Departure of Chief Financial Officer
Chief Executive Officer Brian Schaffner Appointed Interim CFO, Principal Financial and Accounting Officer. REDMOND, Ore., Dec. 20, 2024 (GLOBE NEWSWIRE) -- Expion360 Inc. (Nasdaq: ...